Corporate Profile

Main Patents

Patent Contents Application country / Patent number
Cell proliferation inhibitor using REIC / Dkk-3 gene, cancer diagnostic agent, cancer therapeutic agent, and gene therapy composition Japan / 3813872, 4509018
USA / 9243048
Germany · France · UK / 1234877
Cell death inducing agent of prostate cancer cell using REIC / Dkk-3 gene Japan / 4838236
USA / 8658611
Partial fragment of REIC gene and cancer therapeutic agent containing said fragment Japan / 5356823, 5662534
USA / 8618273, 9475865
Germany · France · UK / 2090654, 2508606
China / 2007780043463.4
India / 291087
Cancer cell death inducing agent having anticancer agent enhancing action in anticancer drug-resistant cancer Japan / 5279235
USA / 8946173
Germany · France · UK / 2213309
China / 200880122369.2
A pharmaceutical composition for inducing dendritic cell-like differentiation from monocytes and for treating or preventing cancer which enhances anticancer immunity activity USA / 8614093
Germany · France · UK / 2275114
China / 20098080116783.7
Korea / 10-1661365
Australia / 2009229756
Singapore / 165046
India / 287896
Malignant mesothelioma therapeutic agent and immunostimulating agent Japan / 5551593
USA / 8658612
Germany · France · UK / 2327779
China / 20098080136054.8
Gene expression upregulation system and vector Japan / 5697042
USA / 9493776
Germany · France · UK / 2508603
China / 20101080061897.9
Korea / 10-1752941
Australia / 2010322723
Singapore / 180934
Russia / 2577971
Israel / 219882
Partial region polypeptide of REIC protein Japan / 5936129
USA / 9644013
China / 201180041601.1.1
REIC expressing adenoviral vector Japan / 6014029
USA / 9222107
Taiwan / I 545196

As of March 31, 2018